0001104659-24-065702.txt : 20240528
0001104659-24-065702.hdr.sgml : 20240528
20240528200313
ACCESSION NUMBER: 0001104659-24-065702
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240523
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirk Sigurd
CENTRAL INDEX KEY: 0001429125
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39294
FILM NUMBER: 24993695
MAIL ADDRESS:
STREET 1: 225 SUMMIT AVENUE
CITY: MONTVALE
STATE: NJ
ZIP: 07645
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Assertio Holdings, Inc.
CENTRAL INDEX KEY: 0001808665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 850598378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 S. SAUNDERS ROAD
STREET 2: SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: (224) 419-7106
MAIL ADDRESS:
STREET 1: 100 S. SAUNDERS ROAD
STREET 2: SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
4
1
tm2415689-6_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-23
0
0001808665
Assertio Holdings, Inc.
ASRT
0001429125
Kirk Sigurd
ASSERTIO HOLDINGS, INC.
100 SOUTH SAUNDERS ROAD, SUITE 300
LAKE FOREST
IL
60045
1
0
0
0
0
Common Stock
2024-05-23
4
A
0
53750
0
A
53750
D
Stock Option (right to buy)
1.01
2024-05-23
4
A
0
81225
0
A
2034-05-23
Common Stock
81225
81225
D
Restricted stock units were granted on the date of the Issuer's 2024 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy. One-third of these restricted stock units are scheduled to vest on each of May 23, 2025, 2026 and 2027, assuming continued service through the applicable vesting date.
Stock options were granted on the date of the Issuer's 2024 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy. One-third of these stock options are scheduled to vest on each of May 23, 2025, 2026 and 2027, assuming continued service through the applicable vesting date.
These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities.
/s/ Sam Schlessinger, Attorney-in-fact for Sigurd C. Kirk
2024-05-28